{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:34:41Z","timestamp":1793388881918,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.bioorg.2022.105799","type":"journal-article","created":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T11:04:11Z","timestamp":1650279851000},"page":"105799","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Hydroxamate and thiosemicarbazone: Two highly promising scaffolds for the development of SARS-CoV-2 antivirals"],"prefix":"10.1016","volume":"124","author":[{"given":"Yin-Sui","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Zhu","family":"Chigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan-Huan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le-Yun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenxin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Wu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bioorg.2022.105799_b0005","doi-asserted-by":"crossref","first-page":"898","DOI":"10.3390\/v13050898","article-title":"Influence of SARS-CoV-2 variant B.1.1.7, vaccination, and public health measures on the spread of SARS-CoV-2","volume":"13","author":"Dimeglio","year":"2021","journal-title":"Viruses"},{"issue":"8","key":"10.1016\/j.bioorg.2022.105799_b0010","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.3390\/pathogens10081030","article-title":"An overview of vaccines against SARS-CoV-2 in the COVID-19 pandemic era","volume":"10","author":"Pascual-Iglesias","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.bioorg.2022.105799_b0015","doi-asserted-by":"crossref","unstructured":"Q.A. Al Khames Aga, W.H. Alkhaffaf, T.H. Hatem, K.F. Nassir, Y. Batineh, A.T. Dahham, D. Shaban, L.A. Al Khames Aga, M.Y.R. Agha, M. Traqchi, Safety of COVID-19 vaccines, J Med Virol, 93 (2021) 6588-6594.","DOI":"10.1002\/jmv.27214"},{"key":"10.1016\/j.bioorg.2022.105799_b0020","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12916-021-02103-4","article-title":"Transmission event of SARS-CoV-2 delta variant reveals multiple vaccine breakthrough infections","volume":"19","author":"Farinholt","year":"2021","journal-title":"BMC Med."},{"key":"10.1016\/j.bioorg.2022.105799_b0025","unstructured":"A. Stern, S. Fleishon, T. Kustin, E. Dotan, M. Mandelboim, O. Erster, E. Mendelson, O. Mor, N.S. Zuckerman, (2021)."},{"issue":"29","key":"10.1016\/j.bioorg.2022.105799_b0030","doi-asserted-by":"crossref","first-page":"19323","DOI":"10.1021\/acsomega.1c03055","article-title":"Conformational variability correlation prediction of transmissibility and neutralization escape ability for multiple mutation SARS-CoV-2 strains using SSSCPreds","volume":"6","author":"Izumi","year":"2021","journal-title":"ACS Omega"},{"issue":"7871","key":"10.1016\/j.bioorg.2022.105799_b0035","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41586-021-03777-9","article-title":"Reduced sensitivity of SARS-CoV-2 variant delta to antibody neutralization","volume":"596","author":"Planas","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2022.105799_b0040","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1021\/acs.jcim.1c00449","article-title":"Dynamic Profiling of beta-coronavirus 3CL M(pro) protease ligand-binding sites","volume":"61","author":"Cho","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2022.105799_b0045","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved alpha-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.bioorg.2022.105799_b0050","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.3390\/molecules26061678","article-title":"Is PF-00835231 a pan-SARS-CoV-2 Mpro inhibitor? a comparative study","volume":"26","author":"Baig","year":"2021","journal-title":"Molecules"},{"issue":"6536","key":"10.1016\/j.bioorg.2022.105799_b0055","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1126\/science.abf1611","article-title":"SARS-CoV-2 M(pro) inhibitors with antiviral activity in a transgenic mouse model","volume":"371","author":"Qiao","year":"2021","journal-title":"Science"},{"issue":"25","key":"10.1016\/j.bioorg.2022.105799_b0060","doi-asserted-by":"crossref","first-page":"16584","DOI":"10.1021\/acsomega.1c01797","article-title":"Inhibition of the 3CL protease and SARS-CoV-2 replication by dalcetrapib","volume":"6","author":"Niesor","year":"2021","journal-title":"ACS Omega"},{"issue":"41","key":"10.1016\/j.bioorg.2022.105799_b0065","doi-asserted-by":"crossref","first-page":"13686","DOI":"10.1039\/D1SC03628A","article-title":"Discovery of SARS-CoV-2 M(pro) peptide inhibitors from modelling substrate and ligand binding","volume":"12","author":"Chan","year":"2021","journal-title":"Chem. Sci."},{"issue":"38","key":"10.1016\/j.bioorg.2022.105799_b0070","doi-asserted-by":"crossref","first-page":"23450","DOI":"10.1039\/D1RA03956C","article-title":"Drug repurposing and computational modeling for discovery of inhibitors of the main protease (Mpro) of SARS-CoV-2","volume":"11","author":"Silva","year":"2021","journal-title":"RSC Adv."},{"issue":"4","key":"10.1016\/j.bioorg.2022.105799_b0075","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3390\/biom11040607","article-title":"SARS-CoV-2 M(pro): a potential target for peptidomimetics and small-molecule inhibitors","volume":"11","author":"Citarella","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.bioorg.2022.105799_b0080","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1021\/acs.jcim.1c00355","article-title":"Structure-based discovery of novel nonpeptide inhibitors targeting SARS-CoV-2 M(pro)","volume":"61","author":"Yang","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2022.105799_b0085","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1080\/14787210.2021.1860020","article-title":"Recent progress in the repurposing of drugs\/molecules for the management of COVID-19","volume":"19","author":"Sharma","year":"2021","journal-title":"Expert. Rev. Anti. Infect. Ther."},{"key":"10.1016\/j.bioorg.2022.105799_b0090","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1021\/acs.jnatprod.0c00968","article-title":"Natural products with potential to treat RNA virus pathogens including SARS-CoV-2","volume":"84","author":"Christy","year":"2021","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2022.105799_b0095","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1039\/D1MD00066G","article-title":"A review of the latest research on M(pro) targeting SARS-COV inhibitors","volume":"12","author":"Yang","year":"2021","journal-title":"RSC Med. Chem."},{"issue":"6557","key":"10.1016\/j.bioorg.2022.105799_b0100","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1126\/science.abg5827","article-title":"Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2","volume":"373","author":"Drayman","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2022.105799_b0105","doi-asserted-by":"crossref","first-page":"16922","DOI":"10.1021\/acs.jmedchem.1c00409","article-title":"Perspectives on SARS-CoV-2 main protease inhibitors","volume":"64","author":"Gao","year":"2021","journal-title":"J. Med. Chem."},{"issue":"6575","key":"10.1016\/j.bioorg.2022.105799_b0110","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19","volume":"374","author":"Owen","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2022.105799_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113667","article-title":"Recent research and development of NDM-1 inhibitors","volume":"223","author":"Wang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105799_b0120","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.1038\/s41467-020-19662-4","article-title":"Crystallographic structure of wild-type SARS-CoV-2 main protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site","volume":"11","author":"Lee","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2022.105799_b0125","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bioorg.2022.105799_b0130","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/cbdd.13990","article-title":"Hydroxamates as a potent skeleton for the development of metallo-\u03b2-lactamase inhibitors","volume":"99","author":"Chigan","year":"2022","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2022.105799_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104576","article-title":"Diaryl-substituted thiosemicarbazone: A potent scaffold for the development of New Delhi metallo-\u03b2-lactamase-1 inhibitors","volume":"107","author":"Li","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2022.105799_b0140","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00604-021-04766-5","article-title":"Peptide substrate screening for the diagnosis of SARS-CoV-2 using fluorescence resonance energy transfer (FRET) assay","volume":"188","author":"Alhadrami","year":"2021","journal-title":"Mikrochim. Acta"},{"key":"10.1016\/j.bioorg.2022.105799_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104889","article-title":"Ebsulfur and Ebselen as highly potent scaffolds for the development of potential SARS-CoV-2 antivirals","volume":"112","author":"Sun","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2022.105799_b0150","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1038\/s41467-021-22362-2","article-title":"Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors","volume":"12","author":"Iketani","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2022.105799_b0155","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1039\/C9MD00455F","article-title":"meta-Substituted benzenesulfonamide: a potent scaffold for the development of metallo-beta-lactamase ImiS inhibitors","volume":"11","author":"Liu","year":"2020","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105799_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131166","article-title":"The iron(III) and nickel(II) complexes with tetradentate thiosemicarbazones. Synthesis, experimental, theoretical characterization, and antiviral effect against SARS-CoV-2","volume":"1246","author":"Atasever Arslan","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2022.105799_b0165","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41422-020-0356-z","article-title":"Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease","volume":"30","author":"Ma","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.bioorg.2022.105799_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104436","article-title":"Hydroxamic acid with benzenesulfonamide: An effective scaffold for the development of broad-spectrum metallo-beta-lactamase inhibitors","volume":"105","author":"Li","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2022.105799_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116179","article-title":"A novel GSK-3 inhibitor binds to GSK-3beta via a reversible, time and Cys-199-dependent mechanism","volume":"40","author":"Ghazanfari","year":"2021","journal-title":"Bioorg. Med. Chem."},{"issue":"21","key":"10.1016\/j.bioorg.2022.105799_b0180","doi-asserted-by":"crossref","first-page":"6974","DOI":"10.1016\/j.bmc.2015.09.036","article-title":"Synthesis and biochemical evaluation of benzoylbenzophenone thiosemicarbazone analogues as potent and selective inhibitors of cathepsin L","volume":"23","author":"Parker","year":"2015","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105799_b0185","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1087057116671509","article-title":"A perspective on the kinetics of covalent and irreversible inhibition","volume":"22","author":"Strelow","year":"2017","journal-title":"SLAS Discov."},{"key":"10.1016\/j.bioorg.2022.105799_b0190","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1021\/acsinfecdis.9b00385","article-title":"Identification of cisplatin and palladium(II) complexes as potent metallo-beta-lactamase inhibitors for targeting carbapenem-resistant enterobacteriaceae","volume":"6","author":"Chen","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.bioorg.2022.105799_b0195","doi-asserted-by":"crossref","DOI":"10.3390\/biom9110699","article-title":"Dithiocarbamate as a valuable scaffold for the inhibition of metallo-beta-lactmases","volume":"9","author":"Ge","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.bioorg.2022.105799_b0200","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jpba.2018.08.017","article-title":"Investigation of the thermal shift assay and its power to predict protein and virus stabilizing conditions","volume":"161","author":"Sviben","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"11","key":"10.1016\/j.bioorg.2022.105799_b0205","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1039\/C7MD00456G","article-title":"Development of NMR and thermal shift assays for the evaluation of Mycobacterium tuberculosis isocitrate lyase inhibitors","volume":"8","author":"Bhusal","year":"2017","journal-title":"Medchemcomm"},{"issue":"6","key":"10.1016\/j.bioorg.2022.105799_b0210","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1021\/acsptsci.0c00130","article-title":"Ebselen, disulfiram, carmofur, PX-12, tideglusib, and shikonin are nonspecific promiscuous SARS-CoV-2 Main protease inhibitors","volume":"3","author":"Ma","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.bioorg.2022.105799_b0215","unstructured":"G.G. Rossetti, M. Ossorio, S. Barriot, L. Tropia, V.S. Dionellis, C. Gorgulla, H. Arthanari, P. Mohr, R. Gamboni, T.D. Halazonetis, (2020)."},{"issue":"5","key":"10.1016\/j.bioorg.2022.105799_b0220","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1039\/D0RA09858B","article-title":"Binding of inhibitors to the monomeric and dimeric SARS-CoV-2 Mpro","volume":"11","author":"Tam","year":"2021","journal-title":"Rsc Adv."},{"key":"10.1016\/j.bioorg.2022.105799_b0225","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1039\/D0CC06870E","article-title":"Mass spectrometry reveals potential of beta-lactams as SARS-CoV-2 M(pro) inhibitors","volume":"57","author":"Malla","year":"2021","journal-title":"Chem. Commun. (Camb.)"},{"key":"10.1016\/j.bioorg.2022.105799_b0230","doi-asserted-by":"crossref","unstructured":"P.W. Thomas, M. Cammarata, J.S. Brodbelt, A.F. Monzingo, R.F. Pratt, W. Fast, A Lysine-Targeted Affinity Label for Serine-beta-Lactamase Also Covalently Modifies New Delhi Metallo-beta-lactamase-1 (NDM-1), Biochemistry 58(25) (2019) 2834-2843.","DOI":"10.1021\/acs.biochem.9b00393"},{"key":"10.1016\/j.bioorg.2022.105799_b0235","doi-asserted-by":"crossref","unstructured":"S.O. Aftab, M.Z. Ghouri, M.U. Masood, Z. Haider, Z. Khan, A. Ahmad, N. Munawar, Analysis of SARS-CoV-2 RNA-dependent RNA polymerase as a potential therapeutic drug target using a computational approach, J Transl Med, 18 (2020) 275.","DOI":"10.1186\/s12967-020-02439-0"},{"issue":"16","key":"10.1016\/j.bioorg.2022.105799_b0240","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1039\/D0PY01751E","article-title":"A quinine-based quaternized polymer: a potent scaffold with bactericidal properties without resistance dagger","volume":"12","author":"Ding","year":"2021","journal-title":"Polym. Chem."},{"key":"10.1016\/j.bioorg.2022.105799_b0245","doi-asserted-by":"crossref","first-page":"105363","DOI":"10.1016\/j.bioorg.2021.105363","article-title":"Discovery of novel oxazole-based macrocycles as anti-coronaviral agents targeting SARS-CoV-2 main protease","volume":"116","author":"Al-Wahaibi","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"27","key":"10.1016\/j.bioorg.2022.105799_b0250","doi-asserted-by":"crossref","first-page":"7043","DOI":"10.1016\/j.biomaterials.2010.05.023","article-title":"Actions of the anti-cancer drug suberoylanilide hydroxamic acid (SAHA) on human breast cancer cytoarchitecture in silicon microstructures","volume":"31","author":"Strobl","year":"2010","journal-title":"Biomaterials"},{"issue":"11","key":"10.1016\/j.bioorg.2022.105799_b0255","doi-asserted-by":"crossref","first-page":"17726","DOI":"10.18632\/oncotarget.14628","article-title":"Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-\u03b1 through up-regulation of TNF receptor 1 in lung cancer cells","volume":"8","author":"You","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2022.105799_b0260","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1111\/bph.14985","article-title":"Overcoming tamoxifen resistance in oestrogen receptor-positive breast cancer using the novel thiosemicarbazone anti-cancer agent, DpC","volume":"177","author":"Maqbool","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.bioorg.2022.105799_b0265","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3390\/biomedicines9101375","article-title":"Synthesis, in silico study, and anti-cancer activity of thiosemicarbazone derivatives","volume":"9","author":"Sibuh","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.bioorg.2022.105799_b0270","doi-asserted-by":"crossref","first-page":"105474","DOI":"10.1016\/j.bioorg.2021.105474","article-title":"Dithiocarbamates combined with copper for revitalizing meropenem efficacy against NDM-1-producing Carbapenem-resistant Enterobacteriaceae","volume":"118","author":"Chen","year":"2022","journal-title":"Bioorg. Chem."},{"issue":"42","key":"10.1016\/j.bioorg.2022.105799_b0275","doi-asserted-by":"crossref","first-page":"35833","DOI":"10.1039\/C6RA02209J","article-title":"Aggregation-induced emission in fluorophores containing a hydrazone structure and a central sulfone: restricted molecular rotation","volume":"6","author":"Li","year":"2016","journal-title":"Rsc Adv."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206822002048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206822002048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:31:54Z","timestamp":1758616314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206822002048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":55,"alternative-id":["S0045206822002048"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.105799","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydroxamate and thiosemicarbazone: Two highly promising scaffolds for the development of SARS-CoV-2 antivirals","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.105799","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105799"}}